Previous Article | Next Article ![]()
Molecular and Cellular Biology, September 2002, p. 6142-6147, Vol. 22, No. 17
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.17.6142-6147.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Laboratory of Molecular and Developmental Biology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892-2730
Received 21 March 2002/ Accepted 3 June 2002
| ABSTRACT |
|---|
|
|
|---|
35%) and preferential reduction of adipose tissue (
77%). Other TKT+/- tissues had moderate (
33%; liver, gonads) or relatively little (
7 to 18%; eye, kidney, heart, brain) reductions in mass. These mice expressed a normal level of growth hormone and reduced leptin levels. No phenotype was observed in the TKT+/- cornea, where TKT is especially abundant in wild-type mice. The small female TKT+/- mice mated infrequently and had few progeny (with a male/female ratio of 1.4:1) when pregnant. Thus, TKT in normal mice appears to be carefully balanced at a threshold level for well-being. Our data suggest that TKT deficiency may have clinical significance in humans and raise the possibility that obesity may be treated by partial inhibition of TKT in adipose tissue. | INTRODUCTION |
|---|
|
|
|---|
Our interest in TKT was stimulated by its abundance in the cornea of mice (25) and rabbits (9). In mice, TKT comprises approximately 10% (25) and aldehyde dehydrogenase class 3 (ALDH3) comprises approximately 40% (4, 16) of the water-soluble protein of the corneal epithelial cells. By analogy with the use of enzymes as lens crystallins, we have speculated that the abundant metabolic enzymes in the cornea may serve a structural as well as metabolic role (4, 21, 22).
In the present investigation we disrupted the TKT gene by homologous recombination to test whether corneal clarity is dependent on the concentration of this enzyme. We were only able to obtain viable TKT+/- mice. While their corneas appeared normal, the TKT haploinsufficient mice were often smaller and the small females were relatively infertile. The sizes of the organs were differentially affected, with adipose tissue being markedly reduced in the TKT+/- mice. It thus appears that in mice, as found earlier in plants (8), a reduction in TKT leads to multiple phenotypes and metabolic disturbances. Moreover, our results suggest that TKT haploinsufficiency or a reduction in TKT activity may have clinical implications in humans.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Enzyme assays. Cell extracts were prepared from tissues of WT and TKT+/- mice in 50 mM triethanolamine-diethanolamine-HCl buffer (18). The enzyme assay was performed by the method of Takeuchi et al. (28), in which the production of 7-sedoheptulose phosphates is measured by a colorimetric assay. The enzyme activities were normalized to protein concentrations.
In vitro embryo culture. Six- to 8-week-old normal-sized female TKT+/- mice were superovulated by intraperitoneal injection of 5 IU of pregnant mare serum gonadotropin (Sigma) followed 48 h later by 5 IU of human chorionic gonadotropin (hCG; Sigma). The females were bred with TKT+/- or WT males immediately after hCG injection. One-cell embryos were isolated from the ampulla tubae of superovulated females 20 h after hCG injection. The embryos were cultured in M16 medium (Sigma) and incubated with 5% CO2 at 37°C, and the culture medium was changed every 24 h. Photographs were taken every day with a Zeiss Axiovert microscope equipped with a digital camera.
Growth hormone and leptin quantitation. Approximately 1 ml of blood was collected from the heart of anesthetized WT and TKT+/- mice and placed into a clean tube. After standing at room temperature for 20 to 30 min, the coagulated blood was centrifuged at 900 x g for 10 min at 4°C The serum was immediately stored at -70°C in a freezer and shipped on dry ice to Ani Lytics Laboratory (Gaithersburg, Md.) for the growth hormone assay. Leptin was measured using a commercially available leptin enzyme-linked immunosorbent assay (ELISA) kit (Crystal Chem Inc.). Samples (5 µl) were measured in duplicate.
| RESULTS |
|---|
|
|
|---|
The initial intercross mating of the TKT+/- mice produced litters with a non-Mendelian distribution of the TKT knockout allele of WT (n = 56), heterozygous (n = 61), and homozygous (n = 0) mice. Moreover, PCR genotyping showed no TKT-null blastocysts (WT/heterozygotes/homozygotes ratio = 1:1:0; n = 10) or embryonic day 6.5 to embryonic day 12.5 embryos. In addition to the absence of TKT-null mice, the expected 2:1 ratio of heterozygous to WT progeny was not observed, although the expected 1:1 ratio was observed in the progeny of matings between TKT+/- and WT mice (Table 1).
|
|
|
|
|
Corneas of TKT+/- mice. Corneal clarity of the TKT+/- mice was indistinguishable from that of the WT mice as judged by visual inspection (Fig. 4A) and slit-lamp biomicroscopy, despite a 50% reduction in the amount of TKT (Fig. 1C). Immunocytochemistry also showed an approximate 50% reduction in the amount of TKT in the corneal epithelial cells (data not shown). The TKT+/- corneas appeared histologically normal (Fig. 4B).
|
| DISCUSSION |
|---|
|
|
|---|
The reason for the 1.4:1 male to female ratio among the TKT+/- progeny is not known. One possibility is that the female TKT+/- embryos are vulnerable during early development. If so, this may be related to the precise time or level at which the endogenous gene begins to be expressed during embryogenesis, which may be influenced by the sex-related genes (11). G6PD, the first enzyme in the PPP, is encoded on the X chromosome. During embryogenesis, it is possible that female embryos express higher levels of G6PD prior to X chromosome inactivation than do the male embryos (11, 20). This, combined with decreased TKT activity, could result in accumulation of PPP intermediates that may be toxic or fail to produce sufficient end products.
Since TKT-null mice were not obtained, the present experiments did not provide insight into the reason for the abundance of TKT in the mouse cornea (21, 22). TKT is concentrated in the corneal epithelium of WT mice (25) as well as enriched in the corneal stroma and endothelium (6) of WT mice. The fact that a 50% reduction in corneal TKT had no detectable effect is analogous to our earlier finding that elimination of ALDH3, the most abundant corneal enzyme and which is also concentrated in the corneal epithelium, had no detectable effect on corneal clarity or structure (16). There was no compensatory protein that accumulated in the corneas of the ALDH3-/- (16) or TKT+/- (present report; data not shown) mice. Thus, it remains an enigma why these metabolic enzymes are so abundant in the cornea.
Fertility problems are a major medical issue affecting more than 10% of married couples in the population (29). The present finding that TKT haploinsufficiency preferentially affects female fertility in mice may provide a new insight into this important medical issue in humans.
We are unaware of TKT mutations associated with human pathologies. However, Alzheimer's disease has been associated with abnormally cleaved TKT (19), and Wernicke-Korsakoff syndrome (13), as well as other pathologies, has been associated with thiamine deficiencies (12, 26). Direct analysis of human TKT cDNAs has indicated that allelic variants of the TKT gene cannot account for Wernicke-Korsakoff syndrome (14). Since TKT appears to be near the threshold level for the well-being of the present TKT+/- mouse, it is possible that these haploinsufficient mice will be useful for generating an animal model for Wernicke-Korsakoff syndrome and other disorders associated with TKT activity.
We do not know whether the reduction in adipose tissue of the small TKT+/- mice is due to an NADPH deficiency that limits production of lipids (10), or to the reduced cell proliferation. The average serum leptin levels were decreased 10-fold in the small TKT+/- male and female mice (data not shown), consistent with the direct relationship between adiposity and leptin in humans (5). The preferential loss of adipose tissue in the haploinsufficient mice suggests that pharmacological lowering of TKT activity might have clinical relevance for treatment of obesity in humans.
Other fat-deficient mouse models exist (15, 23). The white fatless mouse was generated by adipose-specific expression of a dominant-negative b-ZIP transgene (15). In contrast to our TKT+/- mice, the white fatless mice had larger body size and organs than the WT mice.
Finally, our results are consistent with mouse TKT being encoded in a single-copy gene (24) expressed at a threshold level for normal homeostasis. Similarly, a small decrease in TKT activity in tobacco results in decreased ribulose-1,5-diphosphate, photosynthesis, sugars, aromatic amino acids, phenylpropenoid metabolism, chlorophyll, and carotene (8). Our experiments indicate that there is no compensation for loss of a TKT allele by the TKT-like gene (Tktl1) on the X chromosome in mice (30). Mouse Tktl1 is expressed specifically in the gonads, yet we found a 50% reduction in testes TKT activity in the TKT+/- mice. Humans too have one TKT gene (14) and an X-linked TKT-like gene (TKR) that apparently lacks enzyme activity (3). Thus, our findings raise the possibility that mutations of human TKT affecting enzyme activity may affect obesity and female fertility disorders.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Cascante, M., J. J. Centelles, R. L. Veech, W.-N. P. Lee, and L. G. Boros. 2000. Role of thiamin vitamin B-1 and transketolase in tumor cell proliferation. Nutr. Cancer 36:150-154.[CrossRef][Medline]
3. Coy, J. F., S. Dubel, P. Kioschis, K. Thomas, G. Micklem, H. Delius, and A. Poustka. 1996. Molecular cloning of tissue-specific transcripts of a transketolase-related gene: implications for the evolution of new vertebrate genes. Genomics 32:309-316.[CrossRef][Medline]
4. Cuthbertson, R. A., S. I. Tomarev, and J. Piatigorsky. 1992. Taxon-specific recruitment of enzymes as major soluble proteins in the corneal epithelium of three mammals, chicken, and squid. Proc. Natl. Acad. Sci. USA 89:4004-4008.
5. Farooqi, I. S., J. M. Keogh, S. Kamath, S. Jones, W. T. Gibson, R. Trussell, S. A. Jebb, G. Y. Lip, and S. O'Rahilly. 2001. Partial leptin deficiency and adiposity. Nature 414:34-35.[CrossRef][Medline]
6. Guo, J., C. M. Sax, J. Piatigorsky, and F. X. Yu. 1997. Heterogeneous expression of transketolase in ocular tissues. Curr. Eye Res. 16:467-474.[CrossRef][Medline]
7. Havel, P. J. 2000. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc. Nutr. Soc. 59:359-371.[Medline]
8. Henkes, S., U. Sonnewald, R. Badur, R. Flachmann, and M. Stitt. 2001. A small decrease of plastid transketolase activity in antisense tobacco transformants has dramatic effects on photosynthesis and phenylpropanoid metabolism. Plant Cell 13:535-551.
9. Jester, J. V., T. Moller-Pedersen, J. Huang, C. M. Sax, W. T. Kays, H. D. Cavangh, W. M. Petroll, and J. Piatigorsky. 1999. The cellular basis of corneal transparency: evidence for "corneal crystallins." J. Cell Sci. 112:613-622.[Abstract]
10. Kather, H., M. Rivera, and K. Brand. 1972. Interrelationship and control of glucose metabolism and lipogenesis in isolated fat-cells. Effect of the amount of glucose uptake on the rates of the pentose phosphate cycle and of fatty acid synthesis. Biochem. J. 128:1089-1096.[Medline]
11. Kochhar, H. P. S., J. Peippo, and W. A. King. 2001. Sex related embryo development. Theriogenology 55:3-14.[CrossRef][Medline]
12. Kril, J. J. 1996. Neuropathology of thiamine deficiency disorders. Metab. Brain Dis. 11:9-17.[CrossRef][Medline]
13. Martin, P. R., B. A. McCool, and C. K. Singleton. 1995. Molecular genetics of transketolase in the pathogenesis of the Wernicke-Korsakoff syndrome. Metab. Brain Dis. 10:45-55.[CrossRef][Medline]
14. McCool, B. A., S. G. Plonk, P. R. Martin, and C. K. Singleton. 1993. Cloning of human transketolase cDNAs and comparison of the nucleotide sequence of the coding region in Wernicke-Korsakoff and non-Wernicke-Korsakoff individuals. J. Biol. Chem. 268:1397-1404.
15. Moitra, J., M. M. Mason, M. Olive, D. Krylov, O. Krylov, B. Marcus-Samuels, L. Feigenbaum, E. Lee, T. Aoyama, M. Eckhaus, M. L. Reitman, and C. Vinson. 1998. Life without white fat: a transgenic mouse. Genes Dev. 12:3168-3181.
16. Nees, D. W., E. F. Wawrousek, W. G. Robison, Jr., and J. Piatigorsky. 2002. Structurally normal corneas in aldehyde dehydrogenase 3a1-deficient mice. Mol. Cell. Biol. 22:849-855.
17. Nicol, C. J., J. Zielenski, L. C. Tsui, and P. G. Wells. 2000. An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. FASEB J. 14:111-127.
18. Paoletti, F. 1983. Purification and properties of transketolase from fresh rat liver. Arch. Biochem. Biophys. 222:489-496.[CrossRef][Medline]
19. Paoletti, F., A. Mocali, and D. Tombaccini. 1997. Cysteine proteinases are responsible for characteristic transketolase alterations in Alzheimer fibroblasts. J. Cell Physiol. 172:63-68.[CrossRef][Medline]
20. Peters, J., S. T. Ball, D. J. Charles, W. Pretsch, G. Bulfield, D. Miller, and V. M. Chapman. 1988. The localization of G6pd, glucose-6-phosphate dehydrogenase, and mdx, muscular dystrophy in the mouse X chromosome. Genet. Res. 52:195-201.[Medline]
21. Piatigorsky, J. 1998. Gene sharing in lens and cornea: facts and implications. Prog. Retin. Eye Res. 17:145-174.[CrossRef][Medline]
22. Piatigorsky, J. 2001. Enigma of the abundant water-soluble cytoplasmic proteins of the cornea: the "refracton" hypothesis. Cornea 20:853-858.[CrossRef][Medline]
23. Reue, K., and M. Peterfy. 2000. Mouse models of lipodystrophy. Curr. Atheroscler. Rep. 2:390-396.[Medline]
24. Salamon, C., M. Chervenak, J. Piatigorsky, and C. M. Sax. 1998. The mouse transketolase (TKT) gene: cloning, characterization, and functional promoter analysis. Genomics 48:209-220.[CrossRef][Medline]
25. Sax, C. M., C. Salamon, W. T. Kays, J. Guo, F. X. Yu, R. A. Cuthbertson, and J. Piatigorsky. 1996. Transketolase is a major protein in the mouse cornea. J. Biol. Chem. 271:33568-33574.
26. Schenk, G., R. G. Duggleby, and P. F. Nixon. 1998. Properties and functions of the thiamin diphosphate dependent enzyme transketolase. Int. J. Biochem. Cell Biol. 30:1297-1318.[CrossRef][Medline]
27. Schenk, G., R. Layfield, J. M. Candy, R. G. Duggleby, and P. F. Nixon. 1997. Molecular evolutionary analysis of the thiamine-diphosphate-dependent enzyme, transketolase. J. Mol. Evol. 44:552-572.[CrossRef][Medline]
28. Takeuchi, T., K. Nishino, and Y. Itokawa. 1984. Improved determination of transketolase activity in erythrocytes. Clin. Chem. 30:658-661.
29. Templeton, A. 2000. Infertility and the establishment of pregnancyoverview. Br. Med. Bull. 56:577-587.
30. Wang, P. J., J. R. McCarrey, F. Yang, and D. C. Page. 2001. An abundance of X-linked genes expressed in spermatogonia. Nat. Genet. 27:422-426.[CrossRef][Medline]
31. Wood, T. 1985. The pentose phosphate pathway. Academic Press/Harcourt Brace Jovanovich, New York, N.Y.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|